Alignment Healthcare to Participate in the BofA Securities 2023 Health Care Conference
ORANGE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced...
Staff
Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a...
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023
SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...
National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders
ROCKAWAY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced...
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
“Having experienced urine drug testing myself, I know it’s not a pleasant experience for anyone. So, when it came to...
Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
Media Release SYDNEY, AUSTRALIA, April 26, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company...
LianBio Announces Positive Topline Results from Phase 3 EXPLORER-CN Trial Evaluating Mavacamten in Chinese Patients
• Mavacamten met the primary endpoint for the treatment of Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy • Mavacamten demonstrated a...
Sharecare Awards to be hosted at HLTH 2023
Call for entries extended through Friday, May 19; final winners revealed on stage at HLTH 2023 on Monday, Oct. 9ATLANTA,...
TransCode Therapeutics Announces Strategic Expansion of its Product Portfolio
Submits Provisional Patent Application entitled “Nanoparticles Comprising Payloads and Their In Vivo Delivery.”BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- TransCode...
Decentralized Trials & Research Alliance Shares Patient Journey Maps Across Three Therapeutic Areas
Global Cross-Industry Collaboration Continues Sharing Outputs to Improve Research Access SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- The Decentralized...
WellnessSpace Brands Partners with RSG Group to Bring Its Products to Global Fitness Clubs
The partnership establishes WellnessSpace Brands as an approved vendor for RSG Group’s brands, such as Gold’s Gym, McFIT, JOHN REED...
Imprivata OneSign is now recognized as Google Chrome Enterprise Recommended
Imprivata’s single sign-on solution is now Google Chrome Enterprise Recommended (CER), a program aimed at helping organizations find the apps...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
SALT LAKE CITY, UT, April 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - In the first calendar quarter (1Q) of 2023, Utah...
Smart for Life Launches Proprietary New Line of High Protein Ice Cream
Smart for Life Launches Proprietary New Line of Protein-Based Ice Cream Smart for Life Launches Proprietary New Line of Protein-Based...
Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326
BEFORE Unretouched photos, taken in standard lighting. Results may vary. AFTER Unretouched photos, taken in standard lighting. Results may vary....
GRI Bio (NASDAQ: GRI) Announces Appointment of Leanne Kelly as Chief Financial Officer
- Financial executive bringing over 20 years of experience in accounting, finance and management with a foundation established from big...
Bon Natural Life Limited Appoints Wallace Lee as New Chief Financial Officer
XIAN, China, April 25, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of...
Aphaia Pharma Announces Dosing of First Patient in its Phase 2 Trial Evaluating its Lead Candidate APH-012 for Prediabetes
ZUG, Switzerland and SAN JUAN, Puerto Rico, April 25, 2023 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage company harnessing precision-targeted...
Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...